help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Metzger, D.
Right arrow Articles by Chambon, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Metzger, D.
Right arrow Articles by Chambon, P.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*TAMOXIFEN

Molecular Endocrinology, Vol 9, 579-591, Copyright © 1995 by Endocrine Society


ARTICLES

Effect of antagonists on DNA binding properties of the human estrogen receptor in vitro and in vivo

D Metzger, M Berry, S Ali and P Chambon
Institut de Genetique et de Biologie Moleculaire et Cellulaire, Centre National de la Recherche Scientifique, Institut National de la Sante et de la Recherche Medicale/Universite Louis Pasteur, College de France, C.U. de Strasbourg.

Functional analyses, performed with the estrogen receptor (ER) isolated from different sources or produced with various expression systems, led to contradictory results concerning the role of estrogen (E2) and antiestrogens in ER DNA binding. Here we report the DNA-binding properties of the human ER and show that the wild type ER (HEG0) binds in vitro to an estrogen response element (ERE) as a dimer, irrespective of the presence or absence of estrogen. We also show that the two antihormones, 4-hydroxytamoxifen (OHT, a partial ER agonist) and ICI 164,384 (a pure antagonist) do not impair HEG0 dimerization and DNA binding in vitro. Exposure of HEG0 to elevated temperature (37 C) in vitro results in a much faster reduction of its binding capacity to an ERE in the absence of ligand or in the presence of ICI 164,384 than in the presence of either E2 or OHT. The Gly to Val mutation at amino acid 400 present in the human ER that we initially cloned (HE0), is responsible for an even faster heat inactivation of unliganded receptor compared with HEG0 and largely accounts for the previously observed in vitro ligand-dependent DNA binding of ER. We also show that, as previously observed for OHT, ICI 164,384 does not prevent ER binding to an ERE in vivo, even though ICI 164,384 acts as a pure antagonist for transcriptional activation by ER. We discuss these results in the context of a ligand-dependent interaction between the C-terminal region E, which contains the ligand-binding domain, and the N-terminal A/B region, which contains the activation function AF-1.


This article has been cited by other articles:


Home page
Mol. Endocrinol.Home page
J. Ruegg, E. Swedenborg, D. Wahlstrom, A. Escande, P. Balaguer, K. Pettersson, and I. Pongratz
The Transcription Factor Aryl Hydrocarbon Receptor Nuclear Translocator Functions as an Estrogen Receptor {beta}-Selective Coactivator, and Its Recruitment to Alternative Pathways Mediates Antiestrogenic Effects of Dioxin
Mol. Endocrinol., February 1, 2008; 22(2): 304 - 316.
[Abstract] [Full Text] [PDF]


Home page
Biophys. JHome page
W. Y. X. Peh, E. Reimhult, H. F. Teh, J. S. Thomsen, and X. Su
Understanding Ligand Binding Effects on the Conformation of Estrogen Receptor {alpha}-DNA Complexes: A Combinational Quartz Crystal Microbalance with Dissipation and Surface Plasmon Resonance Study
Biophys. J., June 15, 2007; 92(12): 4415 - 4423.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
M. Callige, I. Kieffer, and H. Richard-Foy
CSN5/Jab1 Is Involved in Ligand-Dependent Degradation of Estrogen Receptor {alpha} by the Proteasome
Mol. Cell. Biol., June 1, 2005; 25(11): 4349 - 4358.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
M. H. Herynk and S. A. W. Fuqua
Estrogen Receptor Mutations in Human Disease
Endocr. Rev., December 1, 2004; 25(6): 869 - 898.
[Abstract] [Full Text] [PDF]


Home page
GENES CELLSHome page
S. Ito, K.-i. Takeyama, A. Yamamoto, S. Sawatsubashi, Y. Shirode, A. Kouzmenko, T. Tabata, and S. Kato
In vivo potentiation of human oestrogen receptor {alpha} by Cdk7-mediated phosphorylation
Genes Cells, October 1, 2004; 9(10): 983 - 992.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
X. Li, J. Huang, P. Yi, R. A. Bambara, R. Hilf, and M. Muyan
Single-Chain Estrogen Receptors (ERs) Reveal that the ER{alpha}/{beta} Heterodimer Emulates Functions of the ER{alpha} Dimer in Genomic Estrogen Signaling Pathways
Mol. Cell. Biol., September 1, 2004; 24(17): 7681 - 7694.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
Y. Bai and V. Giguere
Isoform-Selective Interactions between Estrogen Receptors and Steroid Receptor Coactivators Promoted by Estradiol and ErbB-2 Signaling in Living Cells
Mol. Endocrinol., April 1, 2003; 17(4): 589 - 599.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Webb, P. Nguyen, and P. J. Kushner
Differential SERM Effects on Corepressor Binding Dictate ERalpha Activity in Vivo
J. Biol. Chem., February 21, 2003; 278(9): 6912 - 6920.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
E. Demirpence, A. Semlali, J. Oliva, P. Balaguer, E. Badia, M.-J. Duchesne, J.-C. Nicolas, and M. Pons
An Estrogen-responsive Element-targeted Histone Deacetylase Enzyme Has an Antiestrogen Activity That Differs from That of Hydroxytamoxifen
Cancer Res., November 15, 2002; 62(22): 6519 - 6528.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Obrero, D. V. Yu, and D. J. Shapiro
Estrogen Receptor-dependent and Estrogen Receptor-independent Pathways for Tamoxifen and 4-Hydroxytamoxifen-induced Programmed Cell Death
J. Biol. Chem., November 15, 2002; 277(47): 45695 - 45703.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
P. Yi, M. D. Driscoll, J. Huang, S. Bhagat, R. Hilf, R. A. Bambara, and M. Muyan
The Effects of Estrogen-Responsive Element- and Ligand-Induced Structural Changes on the Recruitment of Cofactors and Transcriptional Responses by ER{alpha} and ER{beta}
Mol. Endocrinol., April 1, 2002; 16(4): 674 - 693.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
C. M. Klinge, S. C. Jernigan, and K. E. Risinger
The Agonist Activity of Tamoxifen Is Inhibited by the Short Heterodimer Partner Orphan Nuclear Receptor in Human Endometrial Cancer Cells
Endocrinology, March 1, 2002; 143(3): 853 - 867.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
H. Brady, M. Doubleday, L. M. Gayo-Fung, M. Hickman, S. Khammungkhune, A. Kois, S. Lipps, S. Pierce, N. Richard, G. Shevlin, et al.
Differential Response of Estrogen Receptors alpha and beta to SP500263, a Novel Potent Selective Estrogen Receptor Modulator
Mol. Pharmacol., March 1, 2002; 61(3): 562 - 568.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
S. A. Fannon, R. M. Vidaver, and S. A. Marts
Genome and Hormones: Gender Differences in Physiology: Historical Perspectives: An abridged history of sex steroid hormone receptor action
J Appl Physiol, October 1, 2001; 91(4): 1854 - 1859.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
W. Feng, P. Webb, P. Nguyen, X. Liu, J. Li, M. Karin, and P. J. Kushner
Potentiation of Estrogen Receptor Activation Function 1 (AF-1) by Src/JNK through a Serine 118-Independent Pathway
Mol. Endocrinol., January 1, 2001; 15(1): 32 - 45.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
R. A. Shapiro, C. Xu, and D. M. Dorsa
Differential Transcriptional Regulation of Rat Vasopressin Gene Expression by Estrogen Receptor {alpha} and {beta}
Endocrinology, November 1, 2000; 141(11): 4056 - 4064.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. Dowsett, J. M. Dixon, K. Horgan, J. Salter, M. Hills, and E. Harvey
Antiproliferative Effects of Idoxifene in a Placebo-controlled Trial in Primary Human Breast Cancer
Clin. Cancer Res., June 1, 2000; 6(6): 2260 - 2267.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
G. de Haan, S. Chusacultanachai, C. Mao, B. S. Katzenellenbogen, and D. J. Shapiro
Estrogen Receptor-KRAB Chimeras Are Potent Ligand-dependent Repressors of Estrogen-regulated Gene Expression
J. Biol. Chem., April 28, 2000; 275(18): 13493 - 13501.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
C. C. Zhang, S. Krieg, and D. J. Shapiro
HMG-1 Stimulates Estrogen Response Element Binding by Estrogen Receptor from Stably Transfected HeLa Cells
Mol. Endocrinol., April 1, 1999; 13(4): 632 - 643.
[Abstract] [Full Text]


Home page
Mol. Cell. Biol.Home page
D. Chen, P. E. Pace, R. C. Coombes, and S. Ali
Phosphorylation of Human Estrogen Receptor alpha  by Protein Kinase A Regulates Dimerization
Mol. Cell. Biol., February 1, 1999; 19(2): 1002 - 1015.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
M. Tsai-Pflugfelder, S. M. Gasser, and W. Wahli
Functional Interaction between the Estrogen Receptor and CTF1: Analysis of the Vitellogenin Gene B1 Promoter in Yeast
Mol. Endocrinol., October 1, 1998; 12(10): 1525 - 1541.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
A. Barsalou, W. Gao, S. I. Anghel, J. Carriere, and S. Mader
Estrogen Response Elements Can Mediate Agonist Activity of Anti-estrogens in Human Endometrial Ishikawa Cells
J. Biol. Chem., July 3, 1998; 273(27): 17138 - 17146.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
J. Devin-Leclerc, X. Meng, F. Delahaye, P. Leclerc, E.-E. Baulieu, and M.-G. Catelli
Interaction and Dissociation by Ligands of Estrogen Receptor and Hsp90: The Antiestrogen RU 58668 Induces a Protein Synthesis-Dependent Clustering of the Receptor in the Cytoplasm
Mol. Endocrinol., June 1, 1998; 12(6): 842 - 854.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
E. K. Gass, S. A. Leonhardt, S. K. Nordeen, and D. P. Edwards
The Antagonists RU486 and ZK98299 Stimulate Progesterone Receptor Binding to Deoxyribonucleic Acid in Vitro and in Vivo, but Have Distinct Effects on Receptor Conformation
Endocrinology, April 1, 1998; 139(4): 1905 - 1919.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
W. L. Kraus and J. T. Kadonaga
p300 and estrogen receptor cooperatively activate transcription via differential enhancement of initiation and reinitiation
Genes & Dev., February 1, 1998; 12(3): 331 - 342.
[Abstract] [Full Text]


Home page
Mol. Endocrinol.Home page
C. A. Powers, M. Mathur, B. M. Raaka, D. Ron, and H. H. Samuels
TLS (Translocated-in-Liposarcoma) Is a High-Affinity Interactor for Steroid, Thyroid Hormone, and Retinoid Receptors
Mol. Endocrinol., January 1, 1998; 12(1): 4 - 18.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
A. Tremblay, G. B. Tremblay, C. Labrie, F. Labrie, and V. Giguere
EM-800, a Novel Antiestrogen, Acts as a Pure Antagonist of the Transcriptional Functions of Estrogen Receptors {alpha} and {beta}
Endocrinology, January 1, 1998; 139(1): 111 - 118.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
M. Melamed, E. Castaño, A. C. Notides, and S. Sasson
Molecular and Kinetic Basis for the Mixed Agonist/Antagonist Activity of Estriol
Mol. Endocrinol., November 1, 1997; 11(12): 1868 - 1878.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
P. Pace, J. Taylor, S. Suntharalingam, R. C. Coombes, and S. Ali
Human Estrogen Receptor beta  Binds DNA in a Manner Similar to and Dimerizes with Estrogen Receptor alpha
J. Biol. Chem., October 10, 1997; 272(41): 25832 - 25838.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. M. Cowley, S. Hoare, S. Mosselman, and M. G. Parker
Estrogen Receptors alpha  and beta  Form Heterodimers on DNA
J. Biol. Chem., August 8, 1997; 272(32): 19858 - 19862.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
M. K. K. El-Tanani and C. D. Green
Two Separate Mechanisms for Ligand-Independent Activation of the Estrogen Receptor
Mol. Endocrinol., June 1, 1997; 11(7): 928 - 937.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
S. Thenot, C. Henriquet, H. Rochefort, and V. Cavailles
Differential Interaction of Nuclear Receptors with the Putative Human Transcriptional Coactivator hTIF1
J. Biol. Chem., May 2, 1997; 272(18): 12062 - 12068.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. P. Aumais, H. S. Lee, R. Lin, and J. H. White
Selective Interaction of hsp90 with an Estrogen Receptor Ligand-binding Domain Containing a Point Mutation
J. Biol. Chem., May 2, 1997; 272(18): 12229 - 12235.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
W. P. Bocchinfuso and K. S. Korach
Estrogen Receptor Residues Required for Stereospecific Ligand Recognition and Activation
Mol. Endocrinol., May 1, 1997; 11(5): 587 - 594.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
B. J. Cheskis, S. Karathanasis, and C. R. Lyttle
Estrogen Receptor Ligands Modulate Its Interaction with DNA
J. Biol. Chem., April 25, 1997; 272(17): 11384 - 11391.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
V. A. Dipippo and C. A. Powers
Tamoxifen and ICI 182,780 Interactions with Thyroid Hormone in the Ovariectomized-Thyroidectomized Rat
J. Pharmacol. Exp. Ther., April 1, 1997; 281(1): 142 - 148.
[Abstract] [Full Text]


Home page
Mol. Endocrinol.Home page
G. B. Tremblay, A. Tremblay, N. G. Copeland, D. J. Gilbert, N. A. Jenkins, F. Labrie, and V. Giguère
Cloning, Chromosomal Localization, and Functional Analysis of the Murine Estrogen Receptor {beta}
Mol. Endocrinol., March 1, 1997; 11(3): 353 - 365.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
Y. Lee and J. Gorski
Estrogen-induced transcription of the progesterone receptor gene does not parallel estrogen receptor occupancy
PNAS, December 24, 1996; 93(26): 15180 - 15184.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. S. Lee, J. Aumais, and J. H. White
Hormone-dependent Transactivation by Estrogen Receptor Chimeras That Do Not Interact with hsp90. EVIDENCE FOR TRANSCRIPTIONAL REPRESSORS
J. Biol. Chem., October 18, 1996; 271(42): 25727 - 25730.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
S. Kato, H. Endoh, Y. Masuhiro, T. Kitamoto, S. Uchiyama, H. Sasaki, S. Masushige, Y. Gotoh, E. Nishida, H. Kawashima, et al.
Activation of the Estrogen Receptor Through Phosphorylation by Mitogen-Activated Protein Kinase
Science, December 1, 1995; 270(5241): 1491 - 1494.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
C. Teyssier, K. Belguise, F. Galtier, and D. Chalbos
Characterization of the Physical Interaction between Estrogen Receptor alpha and JUN Proteins
J. Biol. Chem., September 21, 2001; 276(39): 36361 - 36369.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1995 by The Endocrine Society